New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
08:40 EDTABBVAbbVie should be bought on weakness, says BMO Capital
After AbbVie reported stronger than expected results, BMO Capital thinks that concerns about the inventory build at the company's Humira unit is unwarranted. The firm expects the company to deliver a number of potentially positive pipeline updates and is confident about its near-term growth outlook. The firm keeps an Outperform rating on the stock.
News For ABBV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
07:32 EDTABBVJuno pact leaves Celgene set for growth past Revlimid, says Deutsche Bank
Subscribe for More Information
June 26, 2015
12:02 EDTABBVEMA adopts positive opinion on AbbVie's Humira for acne inversa
Subscribe for More Information
June 24, 2015
06:12 EDTABBVAbbVie announces new TURQUOISE-III study results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use